重要内容提示： | 权益变动方向 | 比例增加□ | | 比例减少 | ☑ | | --- | --- | --- | --- | --- | | 权益变动前合计比例 | 8.66% | | | | | 权益变动后合计比例 | 7.66% | | | | | 本次变动是否违反已作出的承诺、 | 是□ | 否☑ | | | | 意向、计划 | | | | | | 是否触发强制要约收购义务 | 是□ | 否☑ | | | | 证券代码：688301 | 证券简称：奕瑞科技 | 公告编号：2025-059 | | --- | --- | --- | | 转债代码：118025 | 转债简称：奕瑞转债 | | 奕瑞电子科技集团股份有限公司 关于持股 5%以上股东权益变动触及 1%刻度的 提示性公告 持股 5%以上股东天津红杉聚业股权投资合伙企业（有限合伙）及其一致行 动人北京红杉信远股权投资中心（有限合伙）保证向本公司提供的信息真实、准 确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息一致。 二、 权益变动触及 1%刻度的基本情况 2025 年 9 月 5 ...

格隆汇9月8日丨奕瑞科技(688301.SH)公布，2025年9月5日，公司收到股东天津红杉聚业股权投资合伙 企业(有限合伙)(以下简称"天津红杉")及其一致行动人北京红杉信远股权投资中心(有限合伙)(以下简 称"北京红杉"，天津红杉、北京红杉合称为"信息披露义务人")发来的《关于奕瑞科技权益变动情况的 告知函》。2025年9月5日，天津红杉、北京红杉通过大宗交易的方式合计减持公司股份2,002,184股，占 公司总股本比例为1.00%，合计持有公司股份数量从17,333,169股减少至15,330,985股，持有公司股份比 例从8.66%减少至7.66%，权益变动触及1%刻度。 ...

Core Points - Yirui Technology (688301) closed at 114.81 yuan on September 5, 2025, down 4.88% from last week's 120.7 yuan [1] - The company's current market capitalization is 22.987 billion yuan, ranking 9th out of 126 in the medical device sector and 805th out of 5152 in the A-share market [1] Trading Information - On September 5, Yirui Technology recorded a large transaction of 222 million yuan [3] Company Announcements - Yirui Technology plans to issue A-shares to specific investors, raising no more than 1.1736 billion yuan for the construction of X-ray vacuum devices and comprehensive solutions [1] - The number of shares to be issued will not exceed 15% of the total share capital before issuance, amounting to no more than 30,032,755 shares [1] - The issuance has been approved by the board of directors, the shareholders' meeting, and has received regulatory approval from the Shanghai Stock Exchange and the China Securities Regulatory Commission [1]

Summary of Key Points Core Viewpoint - On September 5, a total of 25 stocks from the STAR Market experienced block trades, with a cumulative transaction amount of 865 million yuan, indicating active trading in the sector [2]. Group 1: Trading Activity - There were 67 block trades executed, with a total trading volume of 15.79 million shares [2]. - The stock with the highest transaction amount was Yirui Technology, which had 2 block trades totaling 2.22 million yuan [2]. - Other notable stocks in terms of transaction amounts included Lide Harmony and Tonglian Precision, with transaction amounts of 1.28 billion yuan and 1.09 billion yuan, respectively [2]. Group 2: Price and Discount Analysis - The stocks that experienced the highest discount rates relative to their closing prices included Tonglian Precision, Oat Technology, and Zhongchuang Co., with discount rates of 30.47%, 22.49%, and 21.56% respectively [2]. - The average increase for the stocks involved in block trades was 5.29%, with the STAR 50 Index rising by 3.39% on the same day [2]. Group 3: Institutional Participation - Among the block trades, 12 transactions involved institutional buyers or sellers, covering 8 stocks [2]. - The leading stocks in terms of institutional buying were Ailis, Artis, and New Zhisoft, with respective amounts of 29.49 million yuan, 21.14 million yuan, and 10.98 million yuan [2]. Group 4: Fund Flow - Out of the stocks involved in block trades, 12 experienced net inflows from major funds, with the highest net inflows recorded for Borui Pharmaceutical, Huasheng Lithium, and New Zhisoft, amounting to 306 million yuan, 68.38 million yuan, and 19.05 million yuan respectively [3]. - Conversely, the stocks with the highest net outflows included Artis, Lide Harmony, and Juguang Technology, with net outflows of 65.56 million yuan, 58.08 million yuan, and 32.03 million yuan respectively [3].

（原标题：奕瑞科技现2笔大宗交易 总成交金额2.22亿元） | 成交 | 成交金 | | 相对当 | | | | --- | --- | --- | --- | --- | --- | | 量 | 额 | 成交价 | 日 | | | | （万 | （万 | 格 | 收盘折 溢价 | 买方营业部 | 卖方营业部 | | 股） | 元） | （元） | （%） | | | | 136.18 | 15118.47 | 111.02 | -3.30 | 高盛（中国）证券有限责任公司上海浦东 | 华泰证券股份有限公司成都 | | | | | | 新区世纪大道证券营业部 | 蜀金路证券营业部 | | 64.04 | 7109.78 | 111.02 | -3.30 | 高盛（中国）证券有限责任公司上海浦东 | 华泰证券股份有限公司成都 | | | | | | 新区世纪大道证券营业部 | 蜀金路证券营业部 | 奕瑞科技9月5日大宗交易平台共发生2笔成交，合计成交量200.22万股，成交金额2.22亿元。成交价格均 为111.02元，相对今日收盘价折价3.30%。 注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 ...

Group 1 - The trading date for the transactions is September 5, 2025, involving the company Yirui Technology (奕瑞科技) with the stock code 688301 [1] - The transaction price for Yirui Technology was 111.02 yuan, with a total transaction amount of 15,118.47 thousand yuan for one of the trades [1] - The trading volume for the same transaction was 136.18, indicating significant trading activity [1] Group 2 - Another transaction on the same date for Yirui Technology had a total transaction amount of 7,109.78 thousand yuan, maintaining the same transaction price of 111.02 yuan [1] - The trading volume for this second transaction was 64.04, reflecting continued interest in the stock [1]

Company Overview - Yirui Technology Co., Ltd. is located at 999 Huanqiao Road, Pudong New District, Shanghai, established on March 7, 2011, and listed on September 18, 2020 [1] - The company's main business involves the research, production, sales, and service of digital X-ray detectors [1] Revenue Composition - The revenue composition of Yirui Technology is as follows: - Detector sales account for 81.21% - Core component sales contribute 7.66% - Solutions/technical services generate 5.89% - Accessory sales make up 4.57% - Rental income is 0.66% [1] Stock Performance - On September 4, Yirui Technology's stock fell by 5.03%, closing at 111.00 CNY per share, with a trading volume of 257 million CNY and a turnover rate of 1.13%, resulting in a total market capitalization of 22.224 billion CNY [1] Fund Holdings - Tianhong Fund has a significant holding in Yirui Technology, with the Tianhong CSI Pharmaceutical 100A fund (001550) holding 183,000 shares, representing 1.09% of the fund's net value, making it the ninth-largest holding [2] - The Tianhong CSI Pharmaceutical 100A fund was established on June 30, 2015, with a latest scale of 755 million CNY [2] Fund Performance - The Tianhong CSI Pharmaceutical 100A fund has achieved a year-to-date return of 18.58%, ranking 2307 out of 4222 in its category, and a one-year return of 32.54%, ranking 2866 out of 3789 [2]

Group 1 - The core point of the article is that Yirui Technology (688301) plans to raise up to 117,362.27 million yuan through a private placement of A-shares to fund the construction of X-ray vacuum devices and comprehensive solutions [1][3] - On September 3, 2025, Yirui Technology's stock closed at 116.88 yuan, with a 3.18% increase and a turnover rate of 1.33% [1] - The company has received approval from the board of directors, shareholders' meeting, Shanghai Stock Exchange, and the China Securities Regulatory Commission for the issuance [1][3] Group 2 - On September 3, the net outflow of main funds was 17.266 million yuan, accounting for 5.6% of the total transaction amount, while retail investors had a net inflow of 44.8991 million yuan, representing 14.57% of the total transaction amount [1][3] - The total investment for the project funded by the raised capital is 156,313.48 million yuan, with a construction period of 36 months [1]

Core Viewpoint - iRay Group is planning to issue shares to specific investors, with the aim of raising funds for the construction of X-ray vacuum devices and comprehensive solutions, totaling an investment of approximately 1.56 billion yuan, of which 1.17 billion yuan will be funded through this issuance [6][7]. Summary by Sections Company Overview - iRay Group is located at 999 Huanqiao Road, Pudong New District, Shanghai, and is involved in the development and manufacturing of X-ray imaging technology [1]. Issuance Details - The company plans to issue no more than 30,032,755 shares, which is capped at 15% of the total share capital as of June 30, 2025 [6]. - The issuance will be priced at 80% of the average trading price over the 20 trading days prior to the pricing date [3][4]. Use of Proceeds - The net proceeds from the issuance will be allocated to the X-ray vacuum devices and comprehensive solutions project, which has a total investment of 1.56 billion yuan [6][7]. - The company may adjust the investment amounts based on project progress and funding needs [6]. Risk Factors - The company highlights several risks, including the potential inability to absorb new production capacity, insufficient technical development for new products, and increased depreciation from new long-term assets [7][10]. - The company also notes the risk of rapid growth in accounts receivable, which could impact cash flow and operational efficiency [9][11]. Financial Health - As of the end of the reporting period, the company's asset-liability ratio was 50.54%, indicating a significant level of debt [11]. - The company has raised funds through convertible bonds and bank loans to finance various projects, which may lead to further increases in debt levels [11]. Market Environment - The company operates in a competitive landscape with significant players such as GE Healthcare, Siemens, and Philips, which are also its clients [15][16]. - Geopolitical tensions and trade frictions may pose risks to the company's international operations and competitiveness [12].

股票简称：奕瑞科技 股票代码：688301 转债简称：奕瑞转债 转债代码：118025 奕瑞电子科技集团股份有限公司 iRay Group （上海市浦东新区环桥路 999 号） 2024 年度向特定对象发行 A 股股票 募集说明书 保荐机构（主承销商） （北京市朝阳区建国门外大街 1 号国贸大厦 2 座 27 层及 28 层） 二〇二五年八月 奕瑞电子科技集团股份有限公司 募集说明书 声 明 本公司及全体董事、监事、高级管理人员承诺募集说明书及其他信息披露资 料不存在任何虚假记载、误导性陈述或重大遗漏，并对其真实性、准确性及完整 性承担连带赔偿责任。 本公司第一大股东、实际控制人承诺本募集说明书及其他信息披露资料不存 在虚假记载、误导性陈述或重大遗漏，并对其真实性、准确性及完整性承担连带 赔偿责任。 公司负责人、主管会计工作负责人及会计机构负责人保证募集说明书中财务 会计资料真实、完整。 中国证券监督管理委员会、上海证券交易所对本次发行所作的任何决定或意 见，均不表明其对申请文件及所披露信息的真实性、准确性、完整性作出保证， 也不表明其对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断 或保证。任何 ...